Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today announced the availability of a broadcast titled, “Creating Shareholder Value with a Machine-as-a-Service (‘MaaS’) Business Model.” The piece covers various…
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”) has announced that CEO Kirk Huntsman, CFO Brad Amman…
PlantX Life (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has announced that its founder, Sean Dollinger, will be presenting at the Q1 Virtual Investor Summit. The three-day summit is…
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced promising preclinical data for its PH10 drug candidate. The data demonstrate that the…
Vancouver, B.C., Canada –– Nextech AR Solutions (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR.NE) (CSE: NTAR) (FSE: N29), a diversified leading provider of virtual and augmented reality (AR) experience technologies and services for eCommerce,…
Net Element (NASDAQ: NETE) is in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. Mullen today announced that it…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, today announced that Brock Pierce, the entrepreneur, philanthropist and 2020 presidential candidate, has joined its board of directors. According…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has published an update regarding its recent regulatory filing with the U.S. Securities & Exchange Commission (“SEC”) and announced a target…
Uranium Energy (NYSE American: UEC) is a Corpus Christi, Texas-based uranium mining and exploration company that controls one of the largest historical uranium exploration and development databases in the United States. The company’s acquired properties…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Stifel GMP Health…
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China and a member of Oracle PartnerNetwork (“OPN”) is working with Oracle to develop a powerful tailored SaaS offering that empowers companies…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently…
CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter…
Data, not time, is now a company’s most valuable asset Investing in analytics leads to a host of benefits, including higher growth SRAX’s innovative Sequire technology unlocks stock buyers’ behaviors, trends for issuers of publicly…
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH (“3a”) has received EN ISO 13485 certification for…
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), recently submitted an application to the U.S. Food and…
Cancer screenings, treatments declined during COVID-19 pandemic, highlighting need for personalized therapies to improve outcomes Comprehensive genomic, transcriptomic sequencing of patient samples complete, patient outcome data obtained from UPMC-Magee Project is template for future partnerships…
Cybin’s latest offering generated exceptional demand; announces upsize of “bought deal” offering Burgeoning psychedelic sector attracts investors’ attention as compound may prove effective in mental health treatments. Cybin appears set for rapid growth as research…